NCT04761185 2026-02-25
Raltitrexed in HIPEC
Fudan University
Phase 1 Completed
Clinical Trials
6 trialsNCT00002902 2019-03-13
Irinotecan Plus ICI D1694 in Treating Patients With Advanced Solid Tumors
Abramson Cancer Center at Penn Medicine
Phase 1 Completed
NCT00002828 2013-06-21
Chemotherapy With Raltitrexed and Fluorouracil in Treating Patients With Advanced Colorectal Cancer
Memorial Sloan Kettering Cancer Center
Phase 1 Completed
NCT00003109 2013-04-17
Irinotecan Plus Raltitrexed in Treating Patients With Refractory Solid Tumors
Fox Chase Cancer Center
Phase 1 Completed
NCT00003528 2013-01-16
Raltitrexed in Treating Children With Refractory Acute Leukemia
National Cancer Institute (NCI)
Phase 1 Completed
NCT00001341 2008-03-04
A Phase I Trial of ZD1694 (TOMUDEX), an Inhibitor of Thymidylate Synthase, in Pediatric Patients With Advanced Neoplastic Disease
National Institutes of Health Clinical Center (CC)
Phase 1 Completed